Document:

ex1013.htm

EXHIBIT 10.13

 

GUARANTY

 

Dated:  February 15, 2012

 

For sufficient consideration, the receipt and sufficiency of which are hereby acknowledged, and to induce CCR OF MELBOURNE, INC. (“Lender”) to accept that certain Revolving Line of Credit Promissory Note (the “Note”) of even date herewith in the original principal amount of $500,000.00 from FCID MEDICAL, INC. (“Borrower”), and the Loan Agreement dated of even date herewith (the “Loan Agreement”), the undersigned hereby unconditionally guaranties to Lender the prompt payment of all amounts due on the Note and Loan Agreement as and when the same shall become due whether by acceleration, extension or otherwise and the due and prompt performance of all obligations under the Note and the Loan Agreement.  Lender may extend or renew any indebtedness or release any lien or collateral securing same, or waive any rights thereunder, or release any accommodation party or party secondarily liable thereon, all without the acknowledgement and consent of the undersigned and without thereby releasing or diminishing its rights against the undersigned hereunder.  The undersigned waives notice of acceptance of this Guaranty, notice of any extensions of credit or other acts by Lender and waives diligence, presentment, demand, notice, protest and suit by Lender in respect to the indebtedness hereby guaranteed, and Lender may enforce this Guaranty without first suing the Borrower or any other party or proceeding against any security it may have.  The undersigned agrees to pay all costs and expenses, including reasonable attorney fees and other legal expenses whether incurred at or before the trial level and/or in any appellate, bankruptcy or administrative proceeding, paid or incurred by Lender in connection with the enforcement of this Guaranty.  This Guaranty shall bind and inure to the benefit of the successors and assigns of the parties hereto.

 

IN WITNESS WHEREOF, Guarantor has executed this Guaranty as of the day and year first above written.

 

	Signed, sealed and delivered	“GUARANTOR”	 	 
	in the presence of:	 	 	 
	 	MEDICAL BILLING ASSISTANCE, INC.	 	 
	 	 	 	 
	 	By: /s/ Christian C. Romandetti	 	 
	 	Print Name: Christian C. Romandetti	 	 
	 	Title: President	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	Print Name: 	 	 	 
	Print Name:  	 	 	 
	 	 	 	 
	STATE OF FLORIDA	 	 	 
	COUNTY OF BREVARD	 	 	 
	 	 	 	 

The foregoing instrument was acknowledged before me this 15th day of February, 2012, by Christian C. Romandetti, as President of MEDICAL BILLING ASSISTANCE, INC., on behalf of the corporation.  Said person (check one) X is personally known to me,  ̈ produced a driver's license (issued by a state of the United States within the last five (5) years) as identification, or  ̈ produced other identification, to wit:  _______________________.

/s/ Julie L. Hardesty

Print Name: Julie L. Hardesty

Notary Public, State of Florida

Commission No.: DD876139

My Commission Expires: 05/12/2013Exhibit 10.1

STOCK ISSUANCE AGREEMENT

 

 

This STOCK ISSUANCE
AGREEMENT (this “Agreement”) is made and entered into as of November 16, 2011, by and between Trilogy Capital
Partners, Inc. (“Trilogy”) and Liberator, Inc., a Florida corporation (“LUVU” or the “Company”),
with reference to the following facts:

A.                
Trilogy and the Company have concurrently herewith entered into
that certain Letter of Engagement (the “LOE”) pursuant to which the Company has engaged Trilogy to provide investor
relations services.

B.                
This constitutes the Stock Issuance Agreement contemplated by the
LOE.

NOW, THEREFORE, with
reference to the foregoing facts, Trilogy and the Company agree as follows:

1.Issuance of Shares.

 

As a material inducement
to Trilogy to enter into the LOE, the Company shall issue to Trilogy Six Hundred Fifty Thousand (650,000) shares of restricted
common stock of the Company (the “Shares”). The Shares shall be issued in five tranches on the following dates:
Two Hundred Fifty Thousand (250,000) of the Shares shall be issued on execution of the LOE; One Hundred Thousand (100,000) of the
Shares on January 1, 2012; One Hundred Thousand (100,000) of the Shares on February 1, 2012; One Hundred Thousand (100,000) of
the Shares on March 1, 2012 and One Hundred Thousand (100,000) of the Shares on April 1, 2012. The Shares shall be delivered within
three weeks of the contract dates.

 

2.                 
Representations and Warranties of the Company

The Company represents
and warrants to Trilogy as follows:

2.1             
The Company is a corporation duly organized, validly
existing and in good standing under the laws of the state referenced in the first paragraph of this Agreement and has all requisite
corporate power to own, lease and operate its property and to carry on its business as now being conducted and as currently proposed
to be conducted.

2.2             
This Agreement and the LOE have been duly authorized by all necessary
corporate action and constitute valid and binding obligations of the Company, enforceable against the Company in accordance with
their terms, subject, as to enforcement of remedies, to applicable bankruptcy, insolvency, moratorium,
reorganization and similar laws affecting creditors’ rights generally and to general equitable principles.

2.3             
The Shares have been duly authorized and are validly
issued, fully paid and non-assessable.

2.4             
All consents, approvals, orders, authorizations or
registrations, qualifications, declarations or filings with any federal or state governmental authority on the part of the Company
to issue the Shares have been obtained.

3.                 
Representations, Warranties and Agreements of Trilogy

Trilogy represents
and warrants to, and agrees with, the Company as follows:

3.1             
Trilogy is acquiring the Shares for its own account, for investment
purposes only and not with a view to distribution in violation of the Securities Act of 1933, as amended (the “Securities
Act”).

3.2             
Trilogy understands that an investment in the Shares involves a
high degree of risk, and Trilogy has the financial ability to bear the economic risk of this investment in the Shares, including
a complete loss of such investment. 

3.3             
Trilogy has such knowledge and experience in financial and business
matters that it is capable of evaluating the merits and risks of an investment in the Shares and in protecting its own interest
in connection with this transaction.

3.4             
Trilogy understands that the issuance of the Shares to Trilogy has
not been registered under the Securities Act. Trilogy is familiar with the provisions of the Securities Act and Rule 144 thereunder
and understands that the restrictions on transfer of the Shares may result in Trilogy being required to hold the Shares for an
indefinite period of time unless the transfer by the undersigned is registered under the Securities Act.

3.5             
Trilogy agrees that each certificate evidencing the Shares will
bear the following legend (or a legend substantially similar to the following):

“THE SECURITIES
REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) AND MAY NOT BE
EXERCISED, SOLD, PLEDGED OR TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE ACT
OR UNLESS AN EXEMPTION FROM SUCH REGISTRATION IS AVAILABLE.”

4.                 
Miscellaneous

4.1             
Notices. All notices, requests, demands and other
communications (collectively, “Notices”) given pursuant to this Agreement shall be in writing, and shall be
delivered by personal service, courier, facsimile transmission or by United States first class, registered or certified mail, postage
prepaid, addressed to the party at the address set forth on the signature page of this Agreement. Any Notice, other than a Notice
sent by registered or certified mail, shall be effective when received; a Notice sent by registered or certified mail, postage
prepaid return receipt requested, shall be effective on the earlier of when received or the third day following deposit in the
United States mails. Any party may from time to time change its address for further Notices hereunder by giving notice to the other
party in the manner prescribed in this Section.

4.2             
Attorneys Fees. If any action or proceeding
is brought to enforce or interpret any provision of this Agreement, the prevailing party shall be entitled to recover as an element
of its costs, and not its damages, reasonable attorneys’ fees to be fixed by the court.

4.3             
Governing Law. This Agreement is made
and entered into at New York City, N.Y., and shall be governed by New York law without giving effect to the principles of conflicts
of law thereof. The invalidity of any provision shall not affect the remaining provisions. The parties hereby consent to the exclusive
jurisdiction, venue and forum of any state or federal court in New York City, N.Y. with respect to any action, which, in whole
or in part, in any manner arises under or relates to this Agreement.

4.4             
Severability. Whenever possible each provision of
this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this
Agreement shall be or become prohibited or invalid under applicable law, such provision shall be ineffective to the extent of such
prohibition or invalidity without invalidating the remainder of such provision or the remaining provisions of this Agreement.

4.5             
Captions. The various captions of this Agreement are
for reference only and shall not be considered or referred to in resolving questions of interpretation of this Agreement.

4.6             
Counterparts. This Agreement may be executed in any
number of counterparts, each of which shall be deemed to be an original, but all of which together shall constitute one and the
same instrument.

4.7             
Assignment. The registration rights under Section 4 of this
Agreement may be assigned to any purchaser of any of the Shares, whereupon such purchaser shall have all of the rights of Trilogy
with respect to the purchased Shares and shall be subject to all of the obligations of Trilogy with respect to any registration.

IN WITNESS WHEREOF,
the Company and Trilogy have executed this Agreement as of the day and year first above written.

 

LIBERATOR, INC.

2745 Bankers Industrial Drive

Atlanta, GA 30360

 

By:/s/ Louis S Friedman

Its:President and CEO

 

TRILOGY CAPITAL PARTNERS, INC.

2625 Townsgate Road, Suite 330

Westlake Village, CA 91361

By:/s/ A. J. Cervantes

Its:CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00204-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00204-of-00352.parquet"}]]